OptMed

New York, United States Founded: 2007 • Age: 19 yrs
Biocompatible polymers and genitourinary therapeutics are developed and commercialized.
Request Access

About OptMed

OptMed is a company based in New York (United States) founded in 2007.. OptMed has raised $3.78 million across 8 funding rounds. OptMed offers products and services including BlauProtect and SpectrumEX. OptMed operates in a competitive market with competitors including Neomend, Cohera Medical, Sealonix, GATT Technologies BV and Resivant Medical, among others.

  • Headquarter New York, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Optmed, Inc.
Operational Areas
Healthcare → Medical Devices & Diagnostics → →
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3.78 M (USD)

    in 8 rounds

  • Latest Funding Round
    $200 K (USD), Series A

    Jul 29, 2015

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of OptMed

OptMed offers a comprehensive portfolio of products and services, including BlauProtect and SpectrumEX. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Protects intact and damaged skin with CE marking for EU use.

Primary

Adhesive for closing incisions with FDA clearance for medical applications.

Funding Insights of OptMed

OptMed has successfully raised a total of $3.78M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $200 thousand completed in July 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 8
  • Last Round Series A — $200,000
  • First Round

    (01 Sep 2009)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2015 Amount Series A - OptMed Valuation

investors
Mar, 2015 Amount Series A - OptMed Valuation

investors
Jun, 2014 Amount Series A - OptMed Valuation

investors
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners

Investments & Acquisitions by OptMed

Investments
Company Name Description Domain Location Founded Year Amount
Bento Cloud
Bionic investment advisor platform
2016
48East
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
GrabKios by Kudo
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
48East
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - OptMed

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners

Optmed Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of OptMed

OptMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neomend, Cohera Medical, Sealonix, GATT Technologies BV and Resivant Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
Neomend
domain founded_year HQ Location
Provider of air leak sealant for thoracic surgery
Cohera Medical
domain founded_year HQ Location
Develops innovative surgical adhesives and sealants for medical use.
Sealonix
domain founded_year HQ Location
Developer of hemostatic sealants for surgeries
GATT Technologies BV
domain founded_year HQ Location
Polymer-based adhesive tissue tape is developed for surgical sealants.
Resivant Medical
domain founded_year HQ Location
Surgical adhesives for topical skin closure are developed.
Clozex
domain founded_year HQ Location
Wound closure solutions
Company Name Domain Founded year HQ Location Description
inDrive
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
Bolt
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
Gojek
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
Dunzo
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Optmed

Frequently Asked Questions about OptMed

When was OptMed founded?

OptMed was founded in 2007 and raised its 1st funding round 2 years after it was founded.

Where is OptMed located?

OptMed is headquartered in New York, United States. It is registered at New York, New York, United States.

Is OptMed a funded company?

OptMed is a funded company, having raised a total of $3.78M across 8 funding rounds to date. The company's 1st funding round was a Series A of $75K, raised on Sep 01, 2009.

What does OptMed do?

OptMed was founded in 2007 in New York, United States, within the biotechnology sector. Biocompatible polymer platforms are developed for biosurgical adhesives, sealants, and industrial applications. Genitourinary therapeutic platforms are focused on treatments for lower urinary tract conditions, such as overactive bladder and kidney stones. Products like Devakor, a topical skin adhesive used in place of surgical sutures, are included in the portfolio. Operations emphasize commercialization of these medical technologies.

Who are the top competitors of OptMed?

OptMed's top competitors include Neomend, GATT Technologies BV and Sealonix.

What products or services does OptMed offer?

OptMed offers BlauProtect and SpectrumEX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available